Summit Therapeutics, Inc. · 1 day ago
Accounting Manager, R&D
Palo Alto, CA
Full-time
Onsite
Senior Level
$139K/yr - $163K/yr
5+ years expSummit Therapeutics, Inc. is a biopharmaceutical oncology company focused on improving quality of life and addressing serious unmet medical needs. The Accounting Manager (R&D) will manage accounting for clinical trials, ensuring accurate financial reporting and collaboration with cross-functional teams.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Support the monthly close process to ensure timely and accurate financial reporting, with a focus on continuous process improvement and reducing close timelines
Prepare and review high visibility CRO entries, Investigator Grant entries, and other R&D entries
Own/review the accounting and financial tracking for clinical trial accruals, working closely with cross-functional teams to ensure the data is complete, accurate, and audit-compliant
Lead site payments process with 3rd party vendor clinical sites by reviewing invoices, checking them against Clinical Trial Agreements (CTAs), working with the Clinical Operations team and resolving any issues quickly and timely
Collaborate cross-functionally with other teams like Clinical Operations, Vendor Management and Legal to support strategic business objectives and ensure the accuracy of financial information
Maintain and monitor SOX controls related to operational accounting are completed on time and are working as intended. Proactively identify and escalate any control deficiencies
Support financial systems optimization and upgrades, including implementing systems/tools and making the most of Netsuite and Coupa
Assist with audit preparation by gathering needed documents, preparing schedules (PBCs), and responding to audit requests
All other duties as assigned
Qualification
Required
A minimum of 5+ years of experience in accounting /finance
Strong understanding of GAAP, internal controls, SOX controls and month-end close procedures required
Must be proficient in handling large-scale financial data using Excel and financial systems for accurate analysis and reporting
High level of accuracy and attention to detail
Demonstratable experience of working within a fast-paced finance function
Demonstratable experience of prioritizing workload and managing multiple tight deadlines effectively under pressure in a fast-paced environment
Excellent communication skills with the ability to forge strong internal and external working relationships, and the confidence to challenge information constructively
Enthusiastic team player with an approachable manner and an ability to engage with colleagues across the business with a constructive and can-do attitude to deliver the successful completion of team outputs within required deadlines
Preferred
Bachelor's degree in finance, business, accounting or related field preferred
Experience in the life sciences industry, with prior exposure to clinical study accruals strongly preferred
Experience in FP&A, including budgeting, forecasting, variance analysis, and financial modeling
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
201-500 employees
H1B Sponsorship
Summit Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (6)
2023 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.79BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2025-10-21Post Ipo Equity· $500M
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
Leadership Team
Manmeet Soni
Chief Operating Officer and Board Member
Recent News
2025-12-09
2025-12-05
Company data provided by crunchbase